Let’s start with Key Opinion Leaders (KOL).
These folks are highly respected in their field of medical practice.
And biotech firms need them to help with approval for trials, marketing, and insurance to unlock new revenue from doctor prescriptions.
In …
This morning, I took a screenshot of Bitcoin’s key decision zone.
It’s developing at around $32,000, close to the resistance level earlier this spring.
We’re returning to this zone and could see a catalyst by July 31st.
That’s the day …
Political Theater
Something kicked off in Russia over the weekend.
The head of The Wagner Group (Russian state-funded mercenary involved in paramilitary operations in Ukraine and Syria) wasn’t happy about something…
So, he headed to Moscow to chat about it.…
This morning was just another day in paradise (our favorite beach)
The Peak of Mount Stupid
Tucked between a few condos is a beach access point only the locals know about.
The currents were calm enough to get out there …
Here’s a good example of the advantage of being early in biotech.
Before Moderna went public in 2018, it had no products on the market.
It was a microcap focused on the once-obscure niche of messenger RNA …
Eighteen months ago, the market was driven by extreme fear.
Inflation, interest rate hikes, and geopolitical tensions sent stocks tumbling.
When Greed Replaces Fear (And
How to Leverage The Greed Cycle)
Most folks will give anything to recover the …